Data in support of a central role of plasminogen activator inhibitor-2 polymorphism in recurrent cardiovascular disease risk in the setting of high HDL cholesterol and C-reactive protein using Bayesian network modeling
1999 ◽
Vol 1
(2)
◽
pp. 99-104
◽
Keyword(s):
2000 ◽
Vol 2
(4)
◽
pp. 274-279
◽
Keyword(s):
2006 ◽
Vol 106
(3)
◽
pp. 291-297
◽
Keyword(s):
Keyword(s):
Keyword(s):
2008 ◽
Vol 18
(3)
◽
pp. 220-226
◽